ZA944686B - Process for producing hydrophobic polypeptides proteins or peptides - Google Patents

Process for producing hydrophobic polypeptides proteins or peptides

Info

Publication number
ZA944686B
ZA944686B ZA944686A ZA944686A ZA944686B ZA 944686 B ZA944686 B ZA 944686B ZA 944686 A ZA944686 A ZA 944686A ZA 944686 A ZA944686 A ZA 944686A ZA 944686 B ZA944686 B ZA 944686B
Authority
ZA
South Africa
Prior art keywords
peptides
proteins
hydrophobic polypeptides
producing hydrophobic
polypeptides proteins
Prior art date
Application number
ZA944686A
Other languages
English (en)
Inventor
Heinz Doebili
Nicholas Draeger
Gerda Huber Trottman
Peter Jakob
Dietrich Stueber
Original Assignee
Hoffman La Roche A G F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffman La Roche A G F filed Critical Hoffman La Roche A G F
Publication of ZA944686B publication Critical patent/ZA944686B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA944686A 1993-07-06 1994-06-29 Process for producing hydrophobic polypeptides proteins or peptides ZA944686B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93110755 1993-07-06

Publications (1)

Publication Number Publication Date
ZA944686B true ZA944686B (en) 1995-01-06

Family

ID=8213046

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944686A ZA944686B (en) 1993-07-06 1994-06-29 Process for producing hydrophobic polypeptides proteins or peptides

Country Status (14)

Country Link
US (1) US5750374A (de)
EP (2) EP1304381A3 (de)
JP (2) JP2947401B2 (de)
CN (3) CN1057535C (de)
AT (1) ATE236984T1 (de)
AU (1) AU666274B2 (de)
CA (1) CA2125467C (de)
DE (1) DE69432449T2 (de)
DK (1) DK0641861T3 (de)
ES (1) ES2194017T3 (de)
NZ (1) NZ260907A (de)
PT (1) PT641861E (de)
RU (1) RU94023251A (de)
ZA (1) ZA944686B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303567B1 (en) 1995-03-14 2001-10-16 Praecis Pharmaceuticals, Inc . Modulators of β-amyloid peptide aggregation comprising D-amino acids
US5817626A (en) * 1995-03-14 1998-10-06 Praecis Pharmaceuticals Incorporated Modulators of beta-amyloid peptide aggregation
ES2175083T3 (es) 1995-03-14 2002-11-16 Praecis Pharm Inc Moduladores de la agregacion de amiloides.
US5854215A (en) * 1995-03-14 1998-12-29 Praecis Pharmaceuticals Incorporated Modulators of β-amyloid peptide aggregation
GB9618952D0 (en) 1996-09-11 1996-10-23 Sandoz Ltd Process
US6277826B1 (en) 1996-08-27 2001-08-21 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
US5985242A (en) * 1995-10-27 1999-11-16 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
PT1161449E (pt) 1999-03-04 2007-10-12 Praecis Pharm Inc Moduladores de agregação do péptido beta-amilóide compreendendo d-aminoácidos
AU5602100A (en) * 1999-06-09 2000-12-28 Arch Development Corporation Recombinant prion-like genes and proteins and materials and methods comprising same
WO2001029225A1 (en) * 1999-10-21 2001-04-26 Panorama Research, Inc. A general method for optimizing the expression of heterologous proteins
US7799561B2 (en) * 2002-06-12 2010-09-21 Sigma-Aldrich, Co. Affinity peptides and method for purification of recombinant proteins
FR2859221B1 (fr) * 2003-08-28 2005-10-14 Centre Nat Rech Scient Vecteur de co-expression de domaines membranaires de proteines d'enveloppe d'un virus et utilisations
US7741053B2 (en) * 2005-05-13 2010-06-22 Sigma-Aldrich Co. Processes for purification of recombinant proteins
KR100621354B1 (ko) * 2005-06-14 2006-09-08 광주과학기술원 유비퀴틴을 이용한 아밀로이드-베타 펩티드의 제조방법
WO2010063460A1 (en) * 2008-12-02 2010-06-10 Universität Zürich Recombinant production of hydrophobic peptides and fusion proteins for use in producing same
JPWO2016047794A1 (ja) * 2014-09-26 2017-09-28 株式会社カネカ 疎水性ペプチドの製造法
JP6817939B2 (ja) 2014-12-01 2021-01-20 フェネックス インク. ペプチド産生のための融合パートナー
CN105001307B (zh) 2015-07-31 2016-08-24 南京斯拜科生化实业有限公司 一种溶解难溶多肽的偶联肽链及其在液相色谱中分离纯化的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207044A1 (de) * 1985-06-20 1986-12-30 Monsanto Company Freisetzung von Peptiden aus Polypeptiden
EP0212532A1 (de) * 1985-08-12 1987-03-04 Syntex (U.S.A.) Inc. Verfahren zur Herstellung von Fusionsproteinen
JPS63502904A (ja) * 1986-03-24 1988-10-27 オ−ソ・フア−マシユ−チカル・コ−ポレ−シヨン 合成htlv−3ペプチド、その組成物及び用途
CA1304886C (en) * 1986-07-10 1992-07-07 Heinz Dobeli Metal chelate resins
US5047513A (en) * 1986-07-10 1991-09-10 Hoffmann-La Roche Inc. Metal chelate resins
CA1329124C (en) * 1987-02-02 1994-05-03 Jerald C. Sadoff Conjugate malaria vaccine
CA1340522C (en) * 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
US5416007A (en) * 1987-03-20 1995-05-16 Creative Biomolecules, Inc. Enhanced proteolytic cleavage of recombinant fusion proteins
US5124255A (en) * 1988-03-11 1992-06-23 Abbott Laboratories CKS method of protein synthesis
IT1226728B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
US5045190A (en) * 1988-11-08 1991-09-03 Carbonell Ruben G Chromatography apparatus
WO1991019810A1 (en) * 1990-06-15 1991-12-26 California Biotechnology Inc. Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
JPH06500560A (ja) * 1990-08-24 1994-01-20 プレジデント アンド フェローズ オブ ハーバード カレッジ α―アンチキモトリプシン―β―タンパク質複合体形成妨害方法およびその方法に使用する合成ペプチド
DK0770679T4 (da) * 1990-11-03 2010-05-10 Siemens Healthcare Diagnostics HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf
NZ243636A (en) * 1991-07-29 1993-06-25 Iaf Biochem Int Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11
US5434050A (en) * 1991-08-13 1995-07-18 Regents Of The University Of Minnesota Labelled β-amyloid peptide and methods of screening for Alzheimer's disease

Also Published As

Publication number Publication date
EP1304381A3 (de) 2003-05-02
DE69432449T2 (de) 2004-04-08
EP0641861A2 (de) 1995-03-08
RU94023251A (ru) 1996-05-10
AU666274B2 (en) 1996-02-01
EP1304381A2 (de) 2003-04-23
DK0641861T3 (da) 2003-07-28
JPH07102000A (ja) 1995-04-18
CN1916017A (zh) 2007-02-21
JP2947401B2 (ja) 1999-09-13
EP0641861A3 (de) 1997-07-30
CN1098416A (zh) 1995-02-08
CN100439391C (zh) 2008-12-03
CA2125467A1 (en) 1995-01-07
CN1057535C (zh) 2000-10-18
DE69432449D1 (de) 2003-05-15
ES2194017T3 (es) 2003-11-16
CN1227846A (zh) 1999-09-08
JPH1143500A (ja) 1999-02-16
EP0641861B1 (de) 2003-04-09
AU6612294A (en) 1995-01-27
ATE236984T1 (de) 2003-04-15
PT641861E (pt) 2003-07-31
US5750374A (en) 1998-05-12
NZ260907A (en) 1996-06-25
CA2125467C (en) 2001-02-06

Similar Documents

Publication Publication Date Title
ZA944686B (en) Process for producing hydrophobic polypeptides proteins or peptides
DE69020143D1 (de) Verfahren zur verwendung und herstellung von peptiden.
NZ224057A (en) A polypeptide of a vascular anticoagulant protein and method of preparation
CA2220447A1 (en) Novel fusion protein recovery and purification methods
HUT55800A (en) Process for producing anticoagulant peptides
GR3025978T3 (en) Ryegrass pollen allergen
AU3825389A (en) Hcg peptides for use in antibody purification procedures
DE69010155D1 (de) Verfahren zur Trennung von Aminosäuren.
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
HU896448D0 (en) Process for the preparation of anticoagulant peptides
AU7193296A (en) Process for the ultrafiltration of biological matrices comprising peptides or proteins
ATE139572T1 (de) Verfahren zur reinigung von rekombinanten proteinen und dafür nützliche produkte
ATE189232T1 (de) Protein-s polypeptide und deren verwendungen
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
GB2248839B (en) Process for the separation of proteins or polypeptides
EP0425892A3 (en) Process for enhancing the bioavailability of drugs with peptide bonds
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
AU4410689A (en) Method for sequencing peptides or proteins
NO901842D0 (no) Rekombinante fusjonsproteiner for endring av hormonutskillelse.
IL112663A0 (en) Modelling of the three-dimensional structure of peptides, polypeptides and proteins